IP Library › Assignment 063320/0136
Patent Assignment
Reel/Frame 063320/0136

Security Interest

Recorded: 2023-04-13 Pages: 6
Assignor
SPROUT PHARMACEUTICALS, INC.
Executed: 2023-03-31
Assignees
HOLLAND, ANNE
4350 LASSITER AT NORTH HILLS AVE., STE. 260, RALEIGH, NORTH CAROLINA, 27609
MCGLOTHLIN, SANDRA
4350 LASSITER AT NORTH HILLS AVE., STE. 260, RALEIGH, NORTH CAROLINA, 27609
Covered Properties (9)
A Method of Treating Female Hypoactive Desire Disorder with Flibanserin
Patent: 7,151,103 →
Application: 10/272,603 →
Publication: US 2003/0104980
Use of Flibanserin in the Treatment of Obesity
Patent: 8,227,476 →
Application: 11/997,567 →
Publication: US 2008/0242678
Use of Flibanserin in the Treatment of Obesity
Patent: 8,785,458 →
Application: 13/550,062 →
Publication: US 2013/0079355
Treatment of Vasomotor Symptoms
Application: 14/583,275 →
Publication: US 2015/0250783
Use of Flibanserin in the Treatment of Obesity
Patent: 9,730,927 →
Application: 14/940,802 →
Publication: US 2016/0136161
Use of Flibanserin in the Treatment of Obesity
Application: 15/664,163 →
Publication: US 2018/0015084
Treatment of Vasomotor Symptoms
Application: 16/200,004 →
Publication: US 2019/0091219
Use of Flibanserin in the Treatment of Obesity
Application: 16/429,939 →
Publication: US 2019/0282566
Use of Flibanserin in the Treatment of Obesity
Application: 17/101,961 →
Publication: US 2021/0069185
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Dec 21, 2015
From: SPROUT PHARMACEUTICALS, INC., AS GRANTOR; UNILENS VISION INC., AS GRANTOR; COMMONWEALTH LABORATORIES, LLC, AS GRANTOR; SYNERGETICS USA, INC., AS GRANTOR
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 037357/0490 →
Security Agreement May 25, 2017
From: ALDEN OPTICAL LABORATORIES, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 042584/0861 →
Security Interest Jul 19, 2017
From: SPROUT PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0950 →
Security Interest Feb 25, 2021
From: SPROUT PHARMACEUTICALS, INC.
To: GOODRICH, BRAXTON; WHITEHEAD, ROBERT
Reel/Frame 055407/0810 →
Corrective Assignment to Correct the Typographical Error in the Assignment Us Patent 10,098,987 Should Have Been Identified as 10,098,876 and Us Patent 8,785,485 Should Have Been Identified as 8,785,458. Which Incorrectly Identified Previously Recorded on Reel 055407 Frame 0810. Assignor(S) Hereby Confirms the Security Interest. Mar 1, 2021
From: SPROUT PHARMACEUTICALS, INC.
To: GOODRICH, BRAXTON; WHITEHEAD, ROBERT
Reel/Frame 055467/0791 →
Release of Security Interest in Specified Patents Sep 9, 2022
From: THE BANK OF NEW YORK MELLON
To: SPROUT PHARMACEUTICALS, INC.
Reel/Frame 061402/0236 →
Release of Security Interest in Specified Patents Sep 9, 2022
From: BARCLAYS BANK PLC
To: SPROUT PHARMACEUTICALS, INC.
Reel/Frame 061402/0194 →
Release of Security Interest in Specified Patents Sep 9, 2022
From: BARCLAYS BANK PLC
To: SPROUT PHARMACEUTICALS, INC.
Reel/Frame 061401/0684 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →